These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 6760575)

  • 1. [Combination therapy of hypertension. Results of a study with Docidrazin].
    Mörl H
    ZFA (Stuttgart); 1982 Oct; 58(30):1669-74. PubMed ID: 6760575
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hypertension using propranolol combined with hydralazine and a thiazidine diuretic. 1st results].
    Díaz de Losada JM
    Rev Clin Esp; 1975 Dec; 139(6):559-62. PubMed ID: 1215599
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fixed combination of propranolol and bendrofluazide in the treatment of hypertension.
    Jäättelä A
    Ann Clin Res; 1979 Apr; 11(2):80-2. PubMed ID: 378094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension therapy with propanolol and hydralazine].
    Berglund G; Hansson L
    Lakartidningen; 1971 Oct; 68(44):5009-12. PubMed ID: 5135956
    [No Abstract]   [Full Text] [Related]  

  • 6. [Docidrazin. Long-term observation with a 3-component antihypertensive agent].
    Degenring FH
    ZFA (Stuttgart); 1983 Mar; 59(8):476-8. PubMed ID: 6407227
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of hypertension with a combination of the adrenergic beta receptor blockader, obsidan, and the vasodilator, apressin].
    Erina EV; Ozokvo GI; Lediashova GA
    Ter Arkh; 1978; 50(11):112-7. PubMed ID: 725752
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of hypertension with propranolol and bendrofluazide.
    Agrawal RL; Alliott RJ; George M; Gomez G; Trafford JA; Jequier PW; Lishman JD; Turner JR; Baber NS; Dawes PM
    J R Coll Gen Pract; 1979 Oct; 29(207):602-6. PubMed ID: 536969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertension.
    Pandhi P; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):92-4. PubMed ID: 3886568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic time intervals in chronic hypertensives before and after antihypertensive therapy.
    Sanghvi NG; Kapur A; Parikh NK; Khanderia BK; Amin SK; Barbhaiya HC
    Indian Heart J; 1984; 36(6):391-4. PubMed ID: 6399046
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of antihypertensive treatment with labetalol as compared with the combination of hydralazine and propranolol].
    Fea F; Salvioli G; Planca E; Pelliccioli I; Foti F; Colombo G
    Boll Soc Ital Cardiol; 1981; 26(12):2173-82. PubMed ID: 7185386
    [No Abstract]   [Full Text] [Related]  

  • 12. Nepresol in the treatment of hypertension of major severity.
    Németh M; Tényi I; Pár A
    Acta Med Acad Sci Hung; 1979; 36(1):105-17. PubMed ID: 393042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reserpine, hydralazine, hydrochlorothiazide combination (Ser-AP-ES) in essential hypertension.
    Glazer N
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):561-72. PubMed ID: 4628678
    [No Abstract]   [Full Text] [Related]  

  • 14. Double-blind comparison of Inderal LA (160 mg), Half-Inderal LA (80 mg), and Half-Inderal LA plus bendrofluazide (2.5 mg) in the treatment of elderly hypertensive patients.
    Agrawal RL
    Br J Clin Pract; 1987 Sep; 41(9):916-20. PubMed ID: 3330455
    [No Abstract]   [Full Text] [Related]  

  • 15. Propranolol in the treatment of essential hypertension.
    JAMA; 1977 May; 237(21):2303-10. PubMed ID: 323525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Inderex" therapy in general practice.
    Sanderson JH
    Br J Clin Pract; 1985 Mar; 39(3):98-104. PubMed ID: 3885992
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the efficacy and safety of enalapril plus hydrochlorothiazide plus methyldopa vs standard triple therapy in the treatment of moderate to severe hypertension: results from a multicentre study.
    Leonetti G; Cuspidi C; Sampieri L; Ambrosioni E; Malini PL; Pessina A; Semplicini A; Cinotti G; Morabito S; Rappelli A
    J Hum Hypertens; 1990 Feb; 4(1):5-11. PubMed ID: 2189027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.
    Zacest R; Gilmore E; Koch-Weser J
    N Engl J Med; 1972 Mar; 286(12):617-22. PubMed ID: 4401216
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.
    van der Veur E; ten Berge BS; Donker AJ; May JF; Wesseling H
    Eur J Clin Pharmacol; 1982; 21(6):457-60. PubMed ID: 7042373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A combination of propranolol and hydralizine for the treatment of severe hypertension.
    Mehta PJ; Acharya VN; Chawla KP; Gandhi AK; Talwalkar NC
    J Assoc Physicians India; 1981 Feb; 29(2):115-8. PubMed ID: 7263598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.